Search and analyze individual stocks with comprehensive metrics
Raaj Medisafe
Fundamental Score
Raaj Medisafe Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of RAAJMEDI across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (32.48%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (15.02%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 12.94 vs Industry: 23.45)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (50.52%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (45.10%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (23.42% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (47.93% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (72.62% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Balanced Promoter Holding (73.44%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Elevated Debt Levels (D/E: 1.28)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Negative Free Cash Flow (₹-21.19 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Packaging sector...
Financial Statements
Comprehensive financial data for Raaj Medisafe
About RAAJMEDI
Company Details
Market Information
Performance
RAAJMEDI Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of RAAJMEDI?
RAAJMEDI is currently trading at ₹64.85 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of RAAJMEDI shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of RAAJMEDI and what does it mean?
RAAJMEDI has a P/E ratio of 12.94x compared to the industry average of 23.45x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹13 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is RAAJMEDI performing according to Bull Run's analysis?
RAAJMEDI has a Bull Run fundamental score of 68.6/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 32.48%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does RAAJMEDI belong to?
RAAJMEDI operates in the Industrial Products industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Raaj Medisafe. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for RAAJMEDI?
RAAJMEDI has an ROE of 32.48%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Raaj Medisafe generates profits from shareholders' equity. An ROE of 32% means the company generates ₹32 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is RAAJMEDI's debt-to-equity ratio and what does it indicate?
RAAJMEDI has a debt-to-equity ratio of 1.28, which indicates high leverage that increases financial risk. This means the company has ₹128 of debt for every ₹100 of equity. Higher leverage can amplify returns during good times but increases bankruptcy risk during downturns.
What is RAAJMEDI's dividend yield and is it a good dividend stock?
RAAJMEDI offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has RAAJMEDI grown over the past 5 years?
RAAJMEDI has achieved 5-year growth rates of: Sales Growth 23.42%, Profit Growth 72.62%, and EPS Growth 47.93%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in RAAJMEDI and why does it matter?
Promoters hold 73.44% of RAAJMEDI shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does RAAJMEDI compare with its industry peers?
RAAJMEDI trades at P/E 12.94x vs industry average 23.45x, with ROE of 32.48% and ROCE of 15.02%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether RAAJMEDI is outperforming its competitive set in profitability, growth, and valuation metrics.
What is RAAJMEDI's market capitalization and what category does it fall into?
RAAJMEDI has a market capitalization of ₹86 crores, making it a Mid-cap stock. Mid-cap stocks balance growth potential with moderate risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for RAAJMEDI?
Key ratios for RAAJMEDI: ROE 32.48% (Excellent), ROCE 15.02%, P/E 12.94x, Debt-to-Equity 1.28, Interest Coverage 3.27x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is RAAJMEDI stock and what is its beta?
RAAJMEDI has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for RAAJMEDI?
RAAJMEDI has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹64.85, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in RAAJMEDI?
Key risks for RAAJMEDI include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 1.28), and operational challenges. The stock has a Fundamental Score of 68.6/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Industrial Products include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is RAAJMEDI's operating profit margin and how has it trended?
RAAJMEDI has a 5-year average Operating Profit Margin (OPM) of 14.24%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is RAAJMEDI's quarterly performance in terms of sales and profit growth?
RAAJMEDI's recent quarterly performance shows YoY Sales Growth of 45.10% and YoY Profit Growth of 50.52%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in RAAJMEDI?
RAAJMEDI has FII holding of 0.00% and DII holding of 0.00%, totaling 0.00% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.